Adam Cowen is a seasoned senior management professional with over 25 years of experience driving business growth and delivering strategic value in complex and high-risk environments. He has a proven ability to manage large-scale transformation and business change programmes, with budgets up to £200 million, and achieve up to 30% efficiency improvements. Adam has worked across diverse sectors, including healthcare, life science, government, and IT.

His key strengths include:

• Leading large-scale transformation and business change programs.

• Programme governance, risk mitigation, and quality assurance.

• Stakeholder management at all levels, including C-suite, government agencies, and international bodies.

• Financial oversight of multi-million-pound programs.

Adam has a track record of success in delivering impactful change. He directed the world’s largest genomic sequencing project at the Wellcome Sanger Institute, reducing data processing time by 20% and upgrading lab and IT facilities. He also led the UK's first national COVID-19 testing facility, achieving operational readiness in three weeks. Additionally, Adam managed the transformation of ICT services for 17 CCGs, 750 GPs, and 240 staff, achieving a 25% reduction in operating costs and a 20% improvement in service delivery efficiency. He has also led multiple IT Service Management transformation programmes.

A Co-founder and Director at Biomatics and AI Digital, Adam is committed to enhancing service delivery and building sustainable, high-performing teams.

Adam's education includes a BA (Hons) in Business Information Systems, an MSc in Knowledge Management & Consultancy, and certifications in Prince2, MSP, Agile Project Management, ITIL, and Digital Transformation from MIT.